Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (251-260 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p lossWilliam N William, Xin Zhao, Joy J Bianchi, et al.
Cancer Research|September 10, 2009
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer developmentWoo-Young Kim, Quanri Jin, Seung-Hyun Oh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakiaJames L Mulshine, Jane C Atkinson, Robert O Greer, et al.
Plos One|September 3, 2010
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancerMichelle A T Hildebrandt, Ritsuko Komaki, Zhongxing Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reductionKala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.
JAMA Ophthalmology|September 19, 2014
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trialWilliam G Christen, Robert J Glynn, J Michael Gaziano, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3KTianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profilingChi-Pang Wen, Fanmao Zhang, Dong Liang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guidelineKala Visvanathan, Patricia Hurley, Elissa Bantug, et al.
Pageof 34

Showing results (251-260 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p lossWilliam N William, Xin Zhao, Joy J Bianchi, et al.
Cancer Research|September 10, 2009
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer developmentWoo-Young Kim, Quanri Jin, Seung-Hyun Oh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakiaJames L Mulshine, Jane C Atkinson, Robert O Greer, et al.
Plos One|September 3, 2010
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancerMichelle A T Hildebrandt, Ritsuko Komaki, Zhongxing Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reductionKala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.
JAMA Ophthalmology|September 19, 2014
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trialWilliam G Christen, Robert J Glynn, J Michael Gaziano, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3KTianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profilingChi-Pang Wen, Fanmao Zhang, Dong Liang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guidelineKala Visvanathan, Patricia Hurley, Elissa Bantug, et al.
Pageof 34